The full list of family announcements can be found by visiting the Manchester Evening News section of our partner website ...

A hospital has apologised after errors contributed to the death of a 15-year-old girl in its care. Isla Mae Hudson, from ...

An NHS hospital has apologised after the 'completely avoidable' death of a 'full of life' schoolgirl. The heartbroken family ...

An NHS apology has been issued to the family of a 'full of life' schoolgirl whose death was deemed to be 'completely ...

LoQus23 Therapeutics Ltd (“LoQus23”), a private biotechnology company investigating small molecule drugs that could stop the pathogenic triplet expansion that is the cause and driver of Huntington’s ...

With its recent data drop for an oligonucleotide candidate, Dyne Therapeutics signals it may become a frontrunner in this ...

Data from DELIVER and ACHIEVE Clinicals Trial to be Presented - - Presentation on ACHIEVE Trial in DM1 and Company Symposium to Feature Data on the Use of Splicing Correction as a Prognostic Biomarker ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the global licensing and collaboration agreement with Sarepta Therapeutics (NASDAQ ...

Myotonic dystrophy type 1 (DM1) is the most common muscular dystrophy that affects multiple systems including the muscle and heart. The mutant CTG expansion at the 3′-UTR of the DMPK gene causes the ...

In particular, this season shows Messer continuing to be at odds with Ali when the 15-year-old, who lives with Titin Myotonic Muscular Dystrophy, tries to assert more independence without mobility ...

Bristol Myers Squibb’s Opdivo plus Yervoy, as well as Pfizer’s Braftovi, have each shown strong Phase III performances that could position them as new standards of care in certain subtypes of ...

They help doctors identify diseases that affect the nerves and muscles as well as the extent of any damage. This test is used to diagnose myotonic muscular dystrophy, which causes muscles to stay ...